What is a Cancer Transcription Factor? Published on : 01-06-2023 The transcription factor NF-kB controls many distinct genes that have a broad range of activities, including immunological and inflammatory responses. NF-kB is activated in response to suitable cellular stimulation, most often pathogen or stress-related signals. Transcription factors (TFs) are the key players in tumor genesis and development. Their exceptional versatility and efficacy make them appealing prognostic and therapeutic targets. TFs are known to have DNA binding and transactivation domains. Many of them also interact with proteins that are downstream of signaling cascades. It is worth noting that NF-kB activation is often connected with the upregulation of anti-apoptotic genes, hence giving cell survival strategies to endure physiological stress. Furthermore, NF-kB generates cytokines and adhesion molecules essential for the innate immune response to inflammation. Inflammation, in general, and NF-kB, in particular, have a dual function in cancer development. On the one hand, inflammatory stimuli drive cancer cells to produce aberrant NF-kB target gene clusters (see related page), enabling them to grow and increase uncontrolled. On the other hand, NF-kB may be constitutively active in certain cancers and perform pro-tumorogenic tasks such as enhanced cell proliferation, apoptosis resistance, angiogenesis, and invasion. This is one of the primary reasons why many individuals with chronic inflammatory disorders are at a higher risk of cancer. TP53 is one of the most critical transcription factors in cancer, and it is involved in every facet of tumor development and survival. Tumors' capacity to react to therapy and spread to other body regions is included. Wild-type p53 slows cell growth after DNA damage until the damaged cells are healed. A TP53 gene mutation causes the protein to become hyperactive, allowing cells to multiply in ways that lead to cancer. When DNA damage is too severe to repair, TP53 is also responsible for signaling cell death (apoptosis). This can slow the development of malignant cells while activating the immune system to fight malignancies.